Search research articles
Contact Us
Filters
Showing results (161-170 of 385) with videos related to
Page
of 39
Sort By:
Animals : an Open Access Journal From MDPI
|
April 23, 2022
Bicarbonate-Triggered In Vitro Capacitation of Boar Spermatozoa Conveys an Increased Relative Abundance of the Canonical Transient Receptor Potential Cation (TRPC) Channels 3, 4, 6 and 7 and of CatSper-γ Subunit mRNA Transcripts
Estíbaliz Lacalle, César Consuegra, Cristina A Martínez, et al.
International Journal of Environmental Research and Public Health
|
September 20, 2019
Newborn Health Indicators Associated with Maternal Age during First Pregnancy
Leticia Molina-García, Manuel Hidalgo-Ruiz, Ana María Cámara-Jurado, et al.
Cancer Biology & Therapy
|
February 7, 2009
Fenugreek: a naturally occurring edible spice as an anticancer agent
Shabana Shabbeer, Michelle Sobolewski, Ravi Kumar Anchoori, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
October 14, 2008
Response to endothelin-1 in arteries from human colorectal tumours: role of endothelin receptors
Eduardo Ferrero, Maria Labalde, Nuria Fernández, et al.
Journal of Clinical Pathology
|
May 10, 2012
HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
Carlos Gómez-Martin, Elena Garralda, M José Echarri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2012
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer
A Hunter Shain, Craig P Giacomini, Karen Matsukuma, et al.
Molecular Cancer Therapeutics
|
February 3, 2016
SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts
Harrison Kim, Sharon Samuel, Pedro Lopez-Casas, et al.
Molecular Cancer Therapeutics
|
February 20, 2007
Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays
Belen Rubio-Viqueira, Heather Mezzadra, Matthew E Nielsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2006
Pharmacokinetics of cetuximab after administration of escalating single dosing and weekly fixed dosing in patients with solid tumors
Antoinette R Tan, Dirk F Moore, Manuel Hidalgo, et al.
Pharmacology Research & Perspectives
|
December 16, 2014
Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer
Alicia Navarrete, Emily G Armitage, Monica Musteanu, et al.
Page
of 39
Search research articles
Search
Showing results (161-170 of 385) with videos related to
Sort By:
Page
of 39
Animals : an Open Access Journal From MDPI
|
April 23, 2022
Bicarbonate-Triggered In Vitro Capacitation of Boar Spermatozoa Conveys an Increased Relative Abundance of the Canonical Transient Receptor Potential Cation (TRPC) Channels 3, 4, 6 and 7 and of CatSper-γ Subunit mRNA Transcripts
Estíbaliz Lacalle, César Consuegra, Cristina A Martínez, et al.
International Journal of Environmental Research and Public Health
|
September 20, 2019
Newborn Health Indicators Associated with Maternal Age during First Pregnancy
Leticia Molina-García, Manuel Hidalgo-Ruiz, Ana María Cámara-Jurado, et al.
Cancer Biology & Therapy
|
February 7, 2009
Fenugreek: a naturally occurring edible spice as an anticancer agent
Shabana Shabbeer, Michelle Sobolewski, Ravi Kumar Anchoori, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
October 14, 2008
Response to endothelin-1 in arteries from human colorectal tumours: role of endothelin receptors
Eduardo Ferrero, Maria Labalde, Nuria Fernández, et al.
Journal of Clinical Pathology
|
May 10, 2012
HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
Carlos Gómez-Martin, Elena Garralda, M José Echarri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2012
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer
A Hunter Shain, Craig P Giacomini, Karen Matsukuma, et al.
Molecular Cancer Therapeutics
|
February 3, 2016
SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts
Harrison Kim, Sharon Samuel, Pedro Lopez-Casas, et al.
Molecular Cancer Therapeutics
|
February 20, 2007
Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays
Belen Rubio-Viqueira, Heather Mezzadra, Matthew E Nielsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2006
Pharmacokinetics of cetuximab after administration of escalating single dosing and weekly fixed dosing in patients with solid tumors
Antoinette R Tan, Dirk F Moore, Manuel Hidalgo, et al.
Pharmacology Research & Perspectives
|
December 16, 2014
Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer
Alicia Navarrete, Emily G Armitage, Monica Musteanu, et al.
Page
of 39